These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15372301)

  • 1. Patients with mild hypertensive heart disease and left ventricular outflow tract obstruction: treatment with angiotensin II antagonists.
    Nakagawa M; Sano N; Nobe S; Ichinose M; Yonemochi H; Saikawa T
    Heart Vessels; 2004 Sep; 19(5):248-51. PubMed ID: 15372301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mitral valve dysplasia in a cat causing reversible left ventricular hypertrophy and dynamic outflow tract obstruction].
    Kuijpers NW; Szatmári V
    Tijdschr Diergeneeskd; 2011 May; 136(5):326-31. PubMed ID: 21614848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dual blockade of Renin-Angiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized, controlled pilot study.
    Grandi AM; Solbiati F; Laurita E; Maresca AM; Nicolini E; Marchesi C; Gianni M; Guasti L; Venco A
    Am J Hypertens; 2008 Feb; 21(2):231-7. PubMed ID: 18174880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy.
    Taniguchi I; Kawai M; Date T; Yoshida S; Seki S; Taniguchi M; Shimizu M; Mochizuki S
    Circ J; 2006 Aug; 70(8):995-1000. PubMed ID: 16864931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
    Ovchinnikov AG; Serbul VM; Ageev FT
    Ter Arkh; 2009; 81(5):64-71. PubMed ID: 19537590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic exercise-induced left ventricular outflow tract obstruction without left ventricular hypertrophy.
    Alhaj EK; Kim B; Cantales D; Uretsky S; Chaudhry FA; Sherrid MV
    J Am Soc Echocardiogr; 2013 May; 26(5):556-65. PubMed ID: 23534983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased mitral regurgitation during the valsalva maneuver in a patient with pheochromocytoma, uncontrolled hypertension, cardiac hypertrophy, and dynamic outflow tract obstruction.
    Gilman G; Hansen WH; Prasad A; Ommen SR
    Echocardiography; 2006 Jan; 23(1):53-5. PubMed ID: 16412184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.
    Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Maisaidi M; Zanchetti A
    Blood Press; 2006; 15(2):107-15. PubMed ID: 16754274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamic obstruction of the left ventricular outflow tract by prosthesis dysfunction].
    Yang P; Weidinger F; Hassan A; Glogar D
    Z Kardiol; 1995 Apr; 84(4):270-4. PubMed ID: 7785298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular outflow obstruction resulting from insertion of mitral prostheses leaving the native leaflets intact: adverse clinical outcome in seven patients.
    Waggoner AD; Pérez JE; Barzilai B; Rosenbloom M; Eaton MH; Cox JL
    Am Heart J; 1991 Aug; 122(2):483-8. PubMed ID: 1858630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Edge-to-edge technique to treat post-mitral valve repair systolic anterior motion and left ventricular outflow tract obstruction.
    Mascagni R; Al Attar N; Lamarra M; Calvi S; Tripodi A; Mebazaa A; Lessana A
    Ann Thorac Surg; 2005 Feb; 79(2):471-3; discussion 474. PubMed ID: 15680816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angiotensin-converting enzyme inhibitor, enalapril.
    Ciulla MM; Paliotti R; Esposito A; Cuspidi C; Muiesan ML; Rosei EA; Magrini F; Zanchetti A
    J Hypertens; 2009 Mar; 27(3):626-32. PubMed ID: 19262230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine dynamic left ventricular outflow tract obstruction: assessment of myocardial function and clinical outcome.
    Loureiro J; Smith S; Fonfara S; Swift S; James R; Dukes-McEwan J
    J Small Anim Pract; 2008 Nov; 49(11):578-86. PubMed ID: 18684141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful negative inotropic treatment of acute left ventricular outflow tract obstruction by elongated mitral valve leaflet.
    Ayoub C; Ranasinghe I; Yiannikas J
    J Clin Ultrasound; 2014 May; 42(4):245-8. PubMed ID: 24115147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible mechanisms of left ventricular torsion evaluated by cardioreparative effects of telmisartan in patients with hypertension.
    Mizuguchi Y; Oishi Y; Miyoshi H; Iuchi A; Nagase N; Ara N; Oki T
    Eur J Echocardiogr; 2010 Sep; 11(8):690-7. PubMed ID: 20382977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient left ventricular outflow tract obstruction with systolic anterior motion of the mitral valve: A stunning cause.
    Meuwese CL; Boulaksil M; van Dijk J; Polad J; Meijburg HW
    Echocardiography; 2017 Jul; 34(7):1089-1091. PubMed ID: 28497565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apical ballooning syndrome complicated by acute severe mitral regurgitation with left ventricular outflow obstruction--case report.
    Chandrasegaram MD; Celermajer DS; Wilson MK
    J Cardiothorac Surg; 2007 Feb; 2():14. PubMed ID: 17313686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiotensin II receptor blockers--evidence along the cardiovascular continuum].
    Zeller A; Battegay E
    Praxis (Bern 1994); 2005 Apr; 94(15):581-94. PubMed ID: 15884724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstructive left ventricular hypertrophy. Reversibility of outflow tract obstruction by drug therapy.
    Wheeldon NM; Pringle TH; Lipworth BJ
    Q J Med; 1992 Aug; 84(304):629-36. PubMed ID: 1484941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.